Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional tranexamic acid versus topical tretinoin for solar lentigo of the hands
IRCT20250424065457N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid, tretinoin and lidocaine in actinic lentigo (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Number of lentigo macules and Overall lentigo improvement score. Started May 2025; status: completed.
02
Drugs
tranexamic acidtretinoinlidocaine
03
Conditions
actinic lentigo
Beyond the preview
Go deeper on IRCT20250424065457N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250424065457N1.